Investigating how SerpinB2 affects insulin resistance and inflammation
The role of SerpinB2 in insulin resistance and inflammation
This study is looking at a protein called SerpinB2 to see how it might help protect against insulin resistance and inflammation in people with obesity and diabetes, by checking its levels in fat tissue from both diabetic and non-diabetic individuals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11043436 on NIH RePORTER |
What this research studies
This research explores the role of SerpinB2, a protein that may influence insulin resistance and inflammation in obesity. The study examines how levels of SerpinB2 in adipose tissue relate to diabetes and body mass index. By analyzing samples from diabetic and non-diabetic individuals, the researchers aim to understand the protective effects of SerpinB2 against insulin resistance. The methodology includes evaluating the presence of SerpinB2 in macrophages within visceral adipose tissue and its impact on inflammation and glucose metabolism.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with obesity or insulin resistance, particularly those diagnosed with diabetes.
Not a fit: Patients who are not affected by obesity or insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing insulin resistance and obesity-related conditions.
How similar studies have performed: Previous research has indicated that targeting inflammatory pathways can improve insulin sensitivity, suggesting potential success for this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Dutta, Partha — University of Pittsburgh at Pittsburgh
- Study coordinator: Dutta, Partha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.